KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Intuitive Surgical (ISRG) Receivables (2016 - 2026)

Intuitive Surgical has reported Receivables over the past 18 years, most recently at $1.6 billion for Q1 2026.

  • Quarterly Receivables rose 30.17% to $1.6 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $1.6 billion through Mar 2026, up 30.17% year-over-year, with the annual reading at $1.5 billion for FY2025, 24.47% up from the prior year.
  • Receivables was $1.6 billion for Q1 2026 at Intuitive Surgical, up from $1.5 billion in the prior quarter.
  • Over five years, Receivables peaked at $1.6 billion in Q1 2026 and troughed at $889.1 million in Q2 2022.
  • The 5-year median for Receivables is $1.1 billion (2024), against an average of $1.1 billion.
  • Biggest five-year swings in Receivables: surged 38.02% in 2022 and later increased 1.85% in 2023.
  • Tracing ISRG's Receivables over 5 years: stood at $987.1 million in 2022, then grew by 16.54% to $1.2 billion in 2023, then increased by 7.73% to $1.2 billion in 2024, then grew by 24.47% to $1.5 billion in 2025, then grew by 4.75% to $1.6 billion in 2026.
  • According to Business Quant data, Receivables over the past three periods came in at $1.6 billion, $1.5 billion, and $1.3 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.